Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study

Martinón-Torres, F, Salas, A, Rivero-Calle, I, Cebey-López, M, Pardo-Seco, J, Herberg, JA, Boeddha, NP, Klobassa, DS, Secka, F, Paulus, S ORCID: 0000-0002-0703-9114
et al (show 82 more authors) (2018) Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study. The Lancet Child and Adolescent Health, 2 (06). pp. 404-414.

[img] Text
MARTINON-TORRES - 9-MARCH-2018 - EUCLIDS - LANCET clean.docx - Author Accepted Manuscript
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (848kB)


Background Sepsis and severe focal infections represent a substantial disease burden in children admitted to hospital. We aimed to understand the burden of disease and outcomes in children with life-threatening bacterial infections in Europe. Methods The European Union Childhood Life-threatening Infectious Disease Study (EUCLIDS) was a prospective, multicentre, cohort study done in six countries in Europe. Patients aged 1 month to 18 years with sepsis (or suspected sepsis) or severe focal infections, admitted to 98 participating hospitals in the UK, Austria, Germany, Lithuania, Spain, and the Netherlands were prospectively recruited between July 1, 2012, and Dec 31, 2015. To assess disease burden and outcomes, we collected demographic and clinical data using a secured web-based platform and obtained microbiological data using locally available clinical diagnostic procedures. Findings 2844 patients were recruited and included in the analysis. 1512 (53·2%) of 2841 patients were male and median age was 39·1 months (IQR 12·4–93·9). 1229 (43·2%) patients had sepsis and 1615 (56·8%) had severe focal infections. Patients diagnosed with sepsis had a median age of 27·6 months (IQR 9·0–80·2), whereas those diagnosed with severe focal infections had a median age of 46·5 months (15·8–100·4; p<0·0001). Of 2844 patients in the entire cohort, the main clinical syndromes were pneumonia (511 [18·0%] patients), CNS infection (469 [16·5%]), and skin and soft tissue infection (247 [8·7%]). The causal microorganism was identified in 1359 (47·8%) children, with the most prevalent ones being Neisseria meningitidis (in 259 [9·1%] patients), followed by Staphylococcus aureus (in 222 [7·8%]), Streptococcus pneumoniae (in 219 [7·7%]), and group A streptococcus (in 162 [5·7%]). 1070 (37·6%) patients required admission to a paediatric intensive care unit. Of 2469 patients with outcome data, 57 (2·2%) deaths occurred: seven were in patients with severe focal infections and 50 in those with sepsis. Interpretation Mortality in children admitted to hospital for sepsis or severe focal infections is low in Europe. The disease burden is mainly in children younger than 5 years and is largely due to vaccine-preventable meningococcal and pneumococcal infections. Despite the availability and application of clinical procedures for microbiological diagnosis, the causative organism remained unidentified in approximately 50% of patients.

Item Type: Article
Uncontrolled Keywords: EUCLIDS Consortium, Humans, Bacterial Infections, Sepsis, Severity of Illness Index, Cohort Studies, Prospective Studies, Algorithms, Cost of Illness, Child, Preschool, Infant, Infant, Newborn, Europe, Female, Male
Depositing User: Symplectic Admin
Date Deposited: 21 May 2018 07:42
Last Modified: 19 Jan 2023 06:33
DOI: 10.1016/S2352-4642(18)30113-5
Related URLs: